BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8920906)

  • 1. Mechanism-based inactivation of dopamine beta-monooxygenase in adrenal chromaffin cells.
    May SW; Young FK; Powers JL; Gill-Woznichak MM
    Biochem Biophys Res Commun; 1996 Nov; 228(2):278-84. PubMed ID: 8920906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of non-conjugated olefinic substrate analogues with dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
    Sirimanne SR; May SW
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):77-85. PubMed ID: 7864832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based inhibitors of dopamine beta-hydroxylase: inhibition by 2-bromo-3-(p-hydroxyphenyl)-1-propene.
    Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
    Biochemistry; 1984 Jul; 23(16):3590-8. PubMed ID: 6477886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism-based inactivation of dopamine beta-hydroxylase by p-cresol and related alkylphenols.
    Goodhart PJ; DeWolf WE; Kruse LI
    Biochemistry; 1987 May; 26(9):2576-83. PubMed ID: 3607034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olefin oxygenation and N-dealkylation by dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
    Padgette SR; Wimalasena K; Herman HH; Sirimanne SR; May SW
    Biochemistry; 1985 Oct; 24(21):5826-39. PubMed ID: 4084493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbate based novel high affinity alternate reductants and competitive inhibitors of dopamine beta-monooxygenase.
    Wimalasena K; Dharmasena S; Wimalasena DS
    Biochem Biophys Res Commun; 1994 Apr; 200(1):113-9. PubMed ID: 8166679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of dopamine-beta-monooxygenase with lipids: 1. Lipids as modulators of the catalytic activity of the enzyme.
    Boyadzhyan AS; Karagezyan KG
    Biomed Sci; 1990 Apr; 1(4):379-83. PubMed ID: 2133056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based inhibition of dopamine beta-monooxygenase by aldehydes and amides.
    Bossard MJ; Klinman JP
    J Biol Chem; 1986 Dec; 261(35):16421-7. PubMed ID: 3782127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adrenal medullary chromaffin cells by flow cytometry.
    Gilabert JA; Castejón R; Vargas JA; Durántez A; Artalejo AR
    Cytometry; 1999 Sep; 37(1):32-40. PubMed ID: 10451504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Picolinic acids as inhibitors of dopamine beta-monooxygenase: QSAR and putative binding site.
    Dove S
    Arch Pharm (Weinheim); 2004 Dec; 337(12):645-53. PubMed ID: 15597398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in situ kinetics of dopamine beta-hydroxylase in bovine adrenomedullary chromaffin cells. Intravesicular compartmentation reduces apparent affinity for the cofactor ascorbate.
    Menniti FS; Knoth J; Peterson DS; Diliberto EJ
    J Biol Chem; 1987 Jun; 262(16):7651-7. PubMed ID: 3584135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of tyrosine hydroxylase by cGMP-dependent protein kinase in intact bovine chromaffin cells.
    Rodríguez-Pascual F; Ferrero R; Miras-Portugal MT; Torres M
    Arch Biochem Biophys; 1999 Jun; 366(2):207-14. PubMed ID: 10356285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of dopamine-beta-monooxygenase with chromaffin granule membrane lipids.
    Pogosyan AG; Boyajian AS; Mkrtchyan MY; Karagezyan KG
    Biochem Biophys Res Commun; 1992 Oct; 188(2):678-83. PubMed ID: 1445313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On ortho-diphenol oxidase activity of dopamine-beta-monooxygenase.
    Boyajian AS; Nalbandyan RM
    Biochem Biophys Res Commun; 1982 Jun; 106(4):1248-55. PubMed ID: 7115399
    [No Abstract]   [Full Text] [Related]  

  • 15. Bovine chromaffin cell cultures as model to study organophosporus neurotoxicity.
    Quesada E; Sogorb MA; Vilanova E; Carrera V
    Toxicol Lett; 2004 Jun; 151(1):163-70. PubMed ID: 15177651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple assay of dopamine beta-hydroxylase activity in the homogenate of the adrenal medulla.
    Kuzuya H; Nagatsu T
    Enzymologia; 1969 Jan; 36(1):31-8. PubMed ID: 4894373
    [No Abstract]   [Full Text] [Related]  

  • 17. The reduction of membrane-bound dopamine beta-monooxygenase in resealed chromaffin granule ghosts. Is intragranular ascorbic acid a mediator for extragranular reducing equivalents?
    Wimalasena K; Wimalasena DS
    J Biol Chem; 1995 Nov; 270(46):27516-24. PubMed ID: 7499210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha signalling in bovine adrenal chromaffin cells: involvement of signal-transducer and activator of transcription 1 and 2, extracellular signal-regulated protein kinases 1/2 and serine 31 phosphorylation of tyrosine hydroxylase.
    Douglas SA; Bunn SJ
    J Neuroendocrinol; 2009 Mar; 21(3):200-7. PubMed ID: 19207826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine beta-hydroxylase. Inactivation by a suicide substrate.
    Baldoni JM; Villafranca JJ
    J Biol Chem; 1980 Oct; 255(19):8987-90. PubMed ID: 7410403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of several 2-substituted 3-(p-hydroxyphenyl)-1-propenes and their characterization as mechanism-based inhibitors of dopamine beta-hydroxylase.
    Rajashekhar B; Fitzpatrick PF; Colombo G; Villafranca JJ
    J Biol Chem; 1984 Jun; 259(11):6925-30. PubMed ID: 6547138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.